The global non-hospital-based point-of-care diagnostic products industry is poised for exponential growth, as revealed by the latest market research. The market, which was valued at US$ 12.9 billion in 2022, is projected to witness a substantial upsurge, estimated to reach an impressive valuation of US$ 33.6 billion by 2032. This exponential growth is expected to be driven by a robust Compound Annual Growth Rate (CAGR) of 9.1% throughout the forecast period.
The escalating demand for non-hospital-based point-of-care diagnostic products underscores the increasing significance of accessible and rapid diagnostic solutions. These products provide efficient and accurate diagnostic capabilities outside traditional healthcare settings, empowering individuals and healthcare providers with timely insights for informed decision-making.
Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-6717
The shift towards decentralized healthcare and the rising prevalence of chronic diseases have contributed significantly to the burgeoning demand for point-of-care diagnostic products. Additionally, advancements in technology have played a pivotal role in the development of innovative diagnostic tools that offer portability, ease of use, and swift results, further fueling market growth.
The market landscape for non-hospital-based point-of-care diagnostic products encompasses a diverse range of solutions including portable diagnostic devices, rapid tests, and self-testing kits. These products cater to various medical domains such as infectious diseases, cardiovascular disorders, diabetes, and pregnancy testing, among others, thereby addressing a wide spectrum of healthcare needs.
Stakeholders in the healthcare industry are proactively investing in research and development initiatives to introduce novel and sophisticated diagnostic tools that align with evolving consumer preferences and regulatory standards. The emphasis remains on enhancing accuracy, reliability, and user-friendliness, ultimately aiming to improve patient outcomes and streamline healthcare delivery.
As the demand for non-hospital-based point-of-care diagnostic products continues to escalate, companies operating in this space are gearing up to meet the burgeoning needs of consumers worldwide. Market players are poised to leverage technological advancements and strategic collaborations to enhance product portfolios and expand their global footprint.
The projected trajectory of the non-hospital-based point-of-care diagnostic products market showcases immense potential for innovation and growth, presenting lucrative opportunities for stakeholders across the healthcare landscape.
Non-hospital-based POC diagnostic products are used in a wide range of settings, including:
- Clinics and doctor’s offices
- Home healthcare settings
- Schools and workplaces
- Retail pharmacies
- Sports and fitness facilities
These products are used to diagnose a variety of conditions, including infectious diseases, chronic diseases, and allergies.
Get In Touch With Our Analyst To Handle Your Inquiries! https://www.futuremarketinsights.com/ask-question/rep-gb-6717
Some of the key drivers of growth in the non-hospital-based POC diagnostic products market include:
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as diabetes, heart disease, and cancer is increasing worldwide. This is driving the demand for POC diagnostic products that can be used to monitor and manage these conditions.
- Increasing demand for home healthcare: The demand for home healthcare is growing as people are living longer and have more complex medical needs. POC diagnostic products can be used to provide patients with the care they need in the comfort of their own homes.
- Technological advancements in POC diagnostics: Technological advancements are making POC diagnostic products more accurate, reliable, and affordable. This is making them more attractive to patients, clinicians, and healthcare organizations.
Key Takeaways:
- The non-hospital-based point-of-care diagnostic products industry is expected to grow significantly in the coming years, driven by a number of factors, including the increasing prevalence of chronic diseases, the rising geriatric population, and technological advancements.
- The blood glucose testing segment is expected to account for the largest share of the market during the forecast period. This is due to the increasing prevalence of diabetes and the growing demand for self-monitoring devices.
- The infectious diseases testing segment is also expected to grow rapidly, driven by the rising prevalence of infectious diseases such as COVID-19.
- The clinics segment is expected to be the largest end-user segment during the forecast period. However, the home healthcare segment is expected to grow at the fastest CAGR. This is due to the increasing demand for home-based healthcare services.
The non-hospital-based point-of-care diagnostic products industry is a growing market with a lot of potential. Companies that are able to develop innovative and affordable point-of-care diagnostic products are well-positioned to benefit from this growth.
Reveal the Force of Personalization: Embrace Customization in Our Timely Report! https://www.futuremarketinsights.com/customization-available/rep-gb-6717
Key Companies Profiled:
- Abbott Laboratories Inc.
- Siemens Healthcare GmbH
- Bio Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.,
- Roche Diagnostics (H. Hoffman-La Roche Ltd.)
- STD Rapid Test Kits
The non-hospital-based point-of-care diagnostic products industry is segmented by product, application, and end user.
By product:
- Blood glucose testing
- Infectious diseases testing
- Coagulation testing
- Cardiac testing
- Drug testing
- Other products
By application:
- Diabetes management
- Infectious disease management
- Cardiovascular disease management
- Cancer management
- Other applications
By end user:
- Clinics
- Home healthcare
- Retail pharmacies
- Other end users
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
